Molecular Diagnostics and Infectious Disease. The Growth Just Keeps on Growing
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing but is becoming more complex and segmented. Find out what’s happening in this informative report. And find out about the impact of multiplex assays which threaten to change diagnosis and treatment forever.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- Multiplex testing
- pathogen evolution and pandemics
- biotechnology advances in genetics
- climate change
- globalization
- the rise of rapid testing
Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Make investment decisions and valuations with confidence using the latest data.
Table of Contents
Samples
LOADING...
Companies Mentioned
- Abbott Laboratories
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- bioMérieux Diagnostics
- Bio-Rad Laboratories, Inc.
- Cepheid (Danaher)
- Hologic
- Ortho Clinical Diagnostics
- Perkin Elmer.
- Qiagen
- Roche Molecular Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific Inc.